The effects of black seed supplementation on cardiovascular risk factors in patients with nonalcoholic fatty liver disease: A randomized, double‐blind, placebo‐controlled clinical trial

Double Blind ◽

Double Blind Placebo

The effects of Zataria multiflora Boiss. (Shirazi thyme) on nonalcoholic fatty liver disease and insulin resistance: A randomized double-blind placebo-controlled clinical trial

Complementary Therapies in Medicine ◽

10.1016/j.ctim.2018.09.010 ◽

2018 ◽

Vol 41 ◽

pp. 118-123 ◽

Cited By ~ 5

Author(s):

Nasrindokht Zamani ◽

Mesbah Shams ◽

Majid Nimrouzi ◽

Mohammad Mehdi Zarshenas ◽

Amin Abolhasani Foroughi ◽

...

Keyword(s):

Insulin Resistance ◽

Clinical Trial ◽

Liver Disease ◽

Fatty Liver ◽

Fatty Liver Disease ◽

Double Blind ◽

Zataria Multiflora ◽

Double Blind Placebo

The Effects of Ginger Supplementation on Cardiovascular Risk Factors in Patients with Non-alcoholic Fatty Liver Disease: A Randomised, Double-blind, Placebo-controlled Study

journal of ilam university of medical sciences ◽

10.29252/sjimu.25.1.211 ◽

2017 ◽

Vol 25 (1) ◽

pp. 211-219

Author(s):

Mehran Rahimlou ◽

Hoda Ahmadnia ◽

Azita Hekmatdoost ◽

Moayed Alavian ◽

Ali Keshavarz ◽

...

Keyword(s):

Risk Factors ◽

Cardiovascular Risk ◽

Liver Disease ◽

Fatty Liver ◽

Fatty Liver Disease ◽

Controlled Study ◽

Double Blind ◽

Alcoholic Fatty Liver ◽

Double Blind Placebo ◽

Inflammatory markers response to citrulline supplementation in patients with non-alcoholic fatty liver disease: a randomized, double blind, placebo-controlled, clinical trial

BMC Research Notes ◽

10.1186/s13104-019-4130-6 ◽

2019 ◽

Vol 12 (1) ◽

Cited By ~ 7

Author(s):

Zahra Darabi ◽

Mina Darand ◽

Zahra Yari ◽

Mehdi Hedayati ◽

Amirhosein Faghihi ◽

...

Keyword(s):

Clinical Trial ◽

Liver Disease ◽

Fatty Liver ◽

Inflammatory Markers ◽

Fatty Liver Disease ◽

Double Blind ◽

Alcoholic Fatty Liver ◽

Double Blind Placebo ◽

Functions of Coenzyme Q10 Supplementation on Liver Enzymes, Markers of Systemic Inflammation, and Adipokines in Patients Affected by Nonalcoholic Fatty Liver Disease: A Double-Blind, Placebo-Controlled, Randomized Clinical Trial

Journal of the American College of Nutrition ◽

10.1080/07315724.2015.1021057 ◽

2015 ◽

Vol 35 (4) ◽

pp. 346-353 ◽

Cited By ~ 36

Author(s):

Farnaz Farsi ◽

Majid Mohammadshahi ◽

Pezhman Alavinejad ◽

Afshin Rezazadeh ◽

Mehdi Zarei ◽

...

Keyword(s):

Clinical Trial ◽

Liver Disease ◽

Fatty Liver ◽

Coenzyme Q10 ◽

Fatty Liver Disease ◽

Liver Enzymes ◽

Double Blind ◽

Double Blind Placebo ◽

Coenzyme Q10 Supplementation

A double-blind, placebo-controlled randomized trial to evaluate the efficacy of docosahexaenoic acid supplementation on hepatic fat and associated cardiovascular risk factors in overweight children with nonalcoholic fatty liver disease

Nutrition Metabolism and Cardiovascular Diseases ◽

10.1016/j.numecd.2015.04.003 ◽

2015 ◽

Vol 25 (8) ◽

pp. 734-741 ◽

Cited By ~ 41

Author(s):

L. Pacifico ◽

E. Bonci ◽

M. Di Martino ◽

P. Versacci ◽

G. Andreoli ◽

...

Keyword(s):

Risk Factors ◽

Cardiovascular Risk ◽

Liver Disease ◽

Docosahexaenoic Acid ◽

Fatty Liver Disease ◽

Overweight Children ◽

Double Blind ◽

Double Blind Placebo ◽

Hepatic Fat

Effects of Phytosterol Supplementation on Serum Levels of Lipid Profiles, Liver Enzymes, Inflammatory Markers, Adiponectin, and Leptin in Patients Affected by Nonalcoholic Fatty Liver Disease: A Double-Blind, Placebo-Controlled, Randomized Clinical Trial

Journal of the American College of Nutrition ◽

10.1080/07315724.2018.1466739 ◽

2018 ◽

Vol 37 (8) ◽

pp. 651-658 ◽

Cited By ~ 3

Author(s):

Majid Mohammad Shahi ◽

Mohammad Ali Javanmardi ◽

Seyed Saeed Seyedian ◽

Mohammad Hossein Haghighizadeh

Keyword(s):

Clinical Trial ◽

Liver Disease ◽

Fatty Liver ◽

Inflammatory Markers ◽

Fatty Liver Disease ◽

Liver Enzymes ◽

Serum Levels ◽

Double Blind ◽

Double Blind Placebo

Synbiotic supplementation in nonalcoholic fatty liver disease: a randomized, double-blind, placebo-controlled pilot study

American Journal of Clinical Nutrition ◽

10.3945/ajcn.113.068890 ◽

2014 ◽

Vol 99 (3) ◽

pp. 535-542 ◽

Cited By ~ 162

Author(s):

Tannaz Eslamparast ◽

Hossein Poustchi ◽

Farhad Zamani ◽

Maryam Sharafkhah ◽

Reza Malekzadeh ◽

...

Keyword(s):

Liver Disease ◽

Pilot Study ◽

Fatty Liver ◽

Nonalcoholic Fatty Liver Disease ◽

Fatty Liver Disease ◽

Double Blind ◽

Double Blind Placebo ◽

Synbiotic Supplementation

Efficacy of Hijamat (wet cupping therapy) in Iranian patients with nonalcoholic fatty liver disease: a controlled clinical trial

TURKISH JOURNAL OF MEDICAL SCIENCES ◽

10.3906/sag-1907-82 ◽

2020 ◽

Vol 44 (2) ◽

pp. 354-359 ◽

Cited By ~ 1

Author(s):

Homayoon BASHIRI ◽

Arezoo BOZORGOMID ◽

Vahid SHOJAEIMOTLAGH

Keyword(s):

Clinical Trial ◽

Liver Disease ◽

Fatty Liver ◽

Nonalcoholic Fatty Liver Disease ◽

Fatty Liver Disease ◽

Cupping Therapy ◽

Iranian Patients

Effects of phytosomal curcumin on anthropometric parameters, insulin resistance, cortisolemia and non-alcoholic fatty liver disease indices: a double-blind, placebo-controlled clinical trial

European Journal of Nutrition ◽

10.1007/s00394-019-01916-7 ◽

2019 ◽

Vol 59 (2) ◽

pp. 477-483 ◽

Cited By ~ 10

Author(s):

Arrigo F. G. Cicero ◽

Amirhossein Sahebkar ◽

Federica Fogacci ◽

Marilisa Bove ◽

Marina Giovannini ◽

...

Keyword(s):

Insulin Resistance ◽

Clinical Trial ◽

Liver Disease ◽

Fatty Liver Disease ◽

Anthropometric Parameters ◽

Double Blind ◽

Alcoholic Fatty Liver ◽

Double Blind Placebo ◽

Combined cranberry supplementation and weight loss diet in non-alcoholic fatty liver disease: a double-blind placebo-controlled randomized clinical trial

International Journal of Food Sciences and Nutrition ◽

10.1080/09637486.2020.1746957 ◽

2020 ◽

Vol 71 (8) ◽

pp. 991-1000

Author(s):

Razie Hormoznejad ◽

Majid Mohammad Shahi ◽

Fakher Rahim ◽

Bijan Helli ◽

Pezhman Alavinejad ◽

...

Keyword(s):

Clinical Trial ◽

Weight Loss ◽

Liver Disease ◽

Fatty Liver ◽

Randomized Clinical Trial ◽

Fatty Liver Disease ◽

Double Blind ◽

Alcoholic Fatty Liver ◽

Double Blind Placebo ◽